ClearBridge Investments’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

ClearBridge Investments’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-206	Closed	-$20K	–	1038
2020 Q2	$20K	Hold	206	–	–	﹤0.01%	846
2020 Q1	$10K	Sell	206 -7	-3%	-$449	﹤0.01%	956
2019 Q4	$15K	Hold	213	–	–	﹤0.01%	988
2019 Q3	$11K	Hold	213	–	–	﹤0.01%	991
2019 Q2	$11K	Hold	213	–	–	﹤0.01%	994
2019 Q1	$11K	Buy	213 +45	+27%	+$2.07K	﹤0.01%	991
2018 Q4	$8K	Hold	168	–	–	﹤0.01%	1036
2018 Q3	$11K	Hold	168	–	–	﹤0.01%	1052
2018 Q2	$8K	Sell	168 -234	-58%	-$11.3K	﹤0.01%	1037
2018 Q1	$20K	Buy	+402	New	+$20.9K	﹤0.01%	979

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ClearBridge Investments's MYOK Position: Q3 2020 in Review

ClearBridge Investments sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 206 shares — an estimated $20K sold.

ClearBridge Investments first reported a position in MYOK in Q1 2018 and held it in 10 quarters. The position peaked at $20K in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

ClearBridge Investments reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
ClearBridge Investments sold 206 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $20K.
ClearBridge Investments first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 10 quarters.
ClearBridge Investments's MyoKardia, Inc. Common Stock position peaked at $20K in Q2 2020.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.